שווי כולל של החברה: abbvie.com (ABBV)

The price action for AbbVie Inc. (ABBV) shown on this chart allows for a valuation of the business amid the struggle for market share and the risk of losing exclusive drug rights, with the metric standing at 569677.88. The holding company leverages its expertise in developing high-demand biomedical products that ensure high returns. Production capacities are constantly upgraded to expand drug output, supporting the overall efficiency of the enterprise.

Enterprise value represents the total acquisition price of a business, combining market capitalization and net debt minus liquid assets. The active M&A strategy of AbbVie Inc. (ABBV) to refresh its drug portfolio is reflected in the enterprise value, where increased borrowing for M&A transactions directly impacts the company's final capital valuation.